Protective effects of collagen polypeptide from tilapia skin against injuries to the liver and kidneys of mice induced by d-galactose

• Published in: Biomedicine & pharmacotherapy Vol. 117; p. 109204
• Main Authors: Li, Dong-Dong, Li, Wen-Jie, Kong, Song-Zhi, Li, Si-Dong, Guo, Jia-Qi, Guo, Min-Hui, Cai, Ting-Ting, Li, Ning, Chen, Ri-Zhi, Luo, Rong-Qiong, Tan, Wei-Xiang
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.09.2019; Elsevier
• Subjects: Alanine Transaminase - metabolism; Amino acid sequence; Animals; Antioxidants - metabolism; Aspartate Aminotransferases - metabolism; Catalase - metabolism; Collagen - pharmacology; d-galactose; Galactose - adverse effects; Glutathione Peroxidase - metabolism; Hepatic damages; Kidney - drug effects; Kidney - metabolism; Lipid Peroxidation - drug effects; Liver - drug effects; Liver - metabolism; Male; Malondialdehyde - metabolism; Mice; Nephritic injuries; Oxidative stress; Oxidative Stress - drug effects; Peptides - pharmacology; Protective Agents - pharmacology; Superoxide Dismutase - metabolism; Tilapia - metabolism; Tilapia skin collagen polypeptide (TSCP); Tilapia skin collagen polypeptide (TSCP); Amino acid sequence; d-galactose; Oxidative stress; Nephritic injuries; Hepatic damages
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2019.109204

[Display omitted] We wished to investigate the role of a tilapia skin collagen polypeptide (TSCP; molecular weight <3 kDa) in alleviating liver and kidney injuries in aging mice induced by d-galactose (d-gal) and its underlying mechanism of action. First, we characterized TSCP. TSCP was passed through a 3-kDa ultrafiltration membrane, desalted in water by a solid-phase extraction column, purified further by reverse phase-high performance liquid chromatography, and analyzed by electrospray ionization mass spectrometry and tandem mass spectrometry. TSCP contained 17 types of amino acids (AAs) and 41 peptide chains of length 7 AAs to 22 AAs. The content of free AAs and total AAs of TSCP was 13.5% and 93.79%, respectively. Next, we undertook animal experiments. Mice were injected once-daily with D-gal (300 mg/kg body weight, s.c.) for 8 weeks, and TSCP was administered simultaneously once-daily by intragastric gavage. TSCP could visibly improve the decreased body weight, depressed appetite, and mental deterioration of mice triggered by d-gal. TSCP could also alleviate d-gal-induced damage to the liver and kidneys according to histopathology (especially high-dose TSCP). Consistent with these macroscopic and pathologic changes, TSCP could also prevent d-gal-induced increases in serum levels of alanine aminotransferase, aspartate transaminase, alkaline phosphatase, lipid peroxidation, creatinine and uric acid, as well as decreases in serum levels of immunoglobulin (Ig)G and IgM. Moreover, TSCP improved the activities of superoxide dismutase, catalase, and glutathione peroxidase, but also inhibited the increases in the levels of malondialdehyde and inducible nitric oxide synthase expression in the liver and kidneys of d-gal-treated mice. These results suggest that TSCP can alleviate the injuries to the liver and kidneys in aging mice induced by d-gal, and that its mechanism of action might be, at least partially, associated with attenuation of oxidative stress and enhancement of immune function.